Yashi

  Surgical Blades Market Overview   Market Research Future (MRFR) announces the publication of its research report Global Surgical blades Market, 2019–2025. The global surgical blades market was valued at USD 346 million in 2018 with the CAGR of 7.4% during the forecast period of 2019–2025. Surgical blades are the instruments used for tissue dissections and skin incisions at the time of surgery. Surgical blades are available in sterile and non-sterile form of packaging. Surgical scalpel can be disposable or reusable. Reusable scalpels have permanently attached blades that can be sharpened during surgery. Disposable scalpels are used once at a time and have plastic handle attached to it. Various types and size of blades are available depending upon the type of surgical procedures and treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8107 Surgical Blades Market Segmentation The global surgical blades market has been segmented based

  Hemoglobinopathies Market Overview   Hemoglobinopathies are also known as hemoglobinopathy. It is the medical term referred to the group of blood disorders and diseases that affect red blood cells. Hemoglobinopathies are inherited single-gene disorders, and in most cases, it is inherited as autosomal co-dominant traits. The global hemoglobinopathies market is estimated to drive the market growth owing to the rising prevalence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E. Also, a low level of hygiene and poor healthcare infrastructure are some key factors attributing to the growth of the target population in low-income regions such as South-East Asia, the Mediterranean basin, and Africa. However, the lack of treatment and diagnosis awareness may hamper market growth over the forecast period. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8098 Hemoglobinopathies Market Segmentation The global hemoglo

  Tele-Intensive Care Unit Market Overview   Tele-intensive care unit (ICU) are used for the management of various medical complications and to treat critically ill patients by using off-site clinical resources. Tele-intensive care units (ICU) are part of telemedicine, and it uses advanced technology to carry out activities such as monitoring, treatment, and rehabilitation. The rising geriatric population, technological advancements in the healthcare sector, increasing occurrence of chronic disorders in the developed and developing countries, and increasing cases of patients affected by neurological disorders across the globe are the major factors driving the growth of the global tele-intensive care unit (ICU) market . Additionally, increasing R&D spending and aggressive strategies adopted by the top players are fueling the growth of the market during the forecast period. According to the World Health Organization and International Agency for Research on Cancer (IARC) reporte

  Pediatric Catheters Market Overview   The Global Pediatric Catheters Market held a Market Value of USD 5.9 billion in 2018 and is Projected to Grow at a CAGR of 9.6% Over the Forecast Period. Pediatric catheters are thin tube medical device made from high graded material used in the healthcare industry to deliver medications, gases or fluids to patients or to drain bodily fluids such as urine. These are inserted into the body for the treatment of a number of diseases and while performing surgeries. Increasing pediatric population, rising prevalence of congenital heart defects & neurological disorders are positively affecting market growth. According to data published by the Centers for Disease Control and Prevention (CDC) in May 2017, 4,045 children died due to various diseases in the US. Additionally, according to data published by the CDC in November 2018, congenital heart defects affect approximately 1% or near about 40,000 newborn babies in the US every year. On the

  Atorvastatin API Market Overview   The Global Atorvastatin API Market is estimated to be valued at USD 4,25,804.16 thousand by 2023 and is expected to register a CAGR of 3.34% during the forecast period. The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023. North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7730 Atorvastatin API Market Se

  Epilepsy  Market Overview   The global epilepsy market, during the forecast period 2018 to 2023, will register growth at a CAGR of 8.20%. The market for epilepsy is set to reach US$9.50 billion by 2023. As per epilepsy market analysts, the global market is anticipated to witness growth owing to the factors such as increasing incidence of PTE as well as the high sensitivity risk of elderly epilepsy. However, the epilepsy market will face challenges and restraints due to the rise in medication costs and time-consuming prescription approval process during the forecast period 2018 to 2023. The development of experimental medicines in the  epilepsy market  is set to play a key role in determining the growth potential during 2018 to 2023 years.  Analysts have also studied the epilepsy market to understand potential threats and challenges the epilepsy market companies could face.  Although the epilepsy market is poised to grow at a fast pace across diagnosis care, disorder, and end-use segm